Salvatorelli E - Search Results

1

Posaconazole and midostaurin in patients with FLT3-mutated acute myeloid leukemia: Pharmacokinetic interactions and clinical facts in a real life study.

Menna P, Marchesi F, Cattaneo C, Candoni A, Delia M, Nadali G, Vatteroni A, Pasciolla C, Perrone S, Verga L, Armiento D, Del Principe MI, Fracchiolla NS, Salvatorelli E, Lupisella S, Terrenato I, Busca A, Minotti G, Pagano L. Menna P, et al. Among authors: salvatorelli e. Clin Transl Sci. 2023 Oct;16(10):1876-1885. doi: 10.1111/cts.13595. Epub 2023 Jul 28. Clin Transl Sci. 2023. PMID: 37515369 Free PMC article.

2

Doxorubicin-dependent reduction of ferrylmyoglobin and inhibition of lipid peroxidation: implications for cardiotoxicity of anticancer anthracyclines.

Menna P, Salvatorelli E, Giampietro R, Liberi G, Teodori G, Calafiore AM, Minotti G. Menna P, et al. Among authors: salvatorelli e. Chem Res Toxicol. 2002 Sep;15(9):1179-89. doi: 10.1021/tx020055+. Chem Res Toxicol. 2002. PMID: 12230412

3

Oxidative degradation of cardiotoxic anticancer anthracyclines to phthalic acids. Novel function or ferrylmyoglobin.

Cartoni A, Menna P, Salvatorelli E, Braghiroli D, Giampietro R, Animati F, Urbani A, Del Boccio P, Minotti G. Cartoni A, et al. Among authors: salvatorelli e. J Biol Chem. 2004 Feb 13;279(7):5088-99. doi: 10.1074/jbc.M306568200. Epub 2003 Nov 21. J Biol Chem. 2004. PMID: 14634026 Free article.

4

Doxorubicin cardiotoxicity and the control of iron metabolism: quinone-dependent and independent mechanisms.

Minotti G, Recalcati S, Menna P, Salvatorelli E, Corna G, Cairo G. Minotti G, et al. Among authors: salvatorelli e. Methods Enzymol. 2004;378:340-61. doi: 10.1016/S0076-6879(04)78025-8. Methods Enzymol. 2004. PMID: 15038979 Review. No abstract available.

5

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity.

Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Minotti G, et al. Among authors: salvatorelli e. Pharmacol Rev. 2004 Jun;56(2):185-229. doi: 10.1124/pr.56.2.6. Pharmacol Rev. 2004. PMID: 15169927 Review.

6

In vitro modeling of the structure-activity determinants of anthracycline cardiotoxicity.

Menna P, Minotti G, Salvatorelli E. Menna P, et al. Among authors: salvatorelli e. Cell Biol Toxicol. 2007 Jan;23(1):49-62. doi: 10.1007/s10565-006-0143-8. Epub 2006 Oct 9. Cell Biol Toxicol. 2007. PMID: 17031515 Review.

7

Defective taxane stimulation of epirubicinol formation in the human heart: insight into the cardiac tolerability of epirubicin-taxane chemotherapies.

Salvatorelli E, Menna P, Gianni L, Minotti G. Salvatorelli E, et al. J Pharmacol Exp Ther. 2007 Feb;320(2):790-800. doi: 10.1124/jpet.106.116160. Epub 2006 Nov 29. J Pharmacol Exp Ther. 2007. PMID: 17135345

8

Doxorubicin degradation in cardiomyocytes.

Menna P, Salvatorelli E, Minotti G. Menna P, et al. Among authors: salvatorelli e. J Pharmacol Exp Ther. 2007 Jul;322(1):408-19. doi: 10.1124/jpet.107.122820. Epub 2007 Apr 27. J Pharmacol Exp Ther. 2007. PMID: 17468298

9

Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes.

Gianni L, Salvatorelli E, Minotti G. Gianni L, et al. Among authors: salvatorelli e. Cardiovasc Toxicol. 2007;7(2):67-71. doi: 10.1007/s12012-007-0013-5. Cardiovasc Toxicol. 2007. PMID: 17652806 Review.

10

Cardiotoxicity of antitumor drugs.

Menna P, Salvatorelli E, Minotti G. Menna P, et al. Among authors: salvatorelli e. Chem Res Toxicol. 2008 May;21(5):978-89. doi: 10.1021/tx800002r. Epub 2008 Apr 1. Chem Res Toxicol. 2008. PMID: 18376852

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

57 results

Search Page